| 摘要 |
Disclosed are an orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases, which comprises an interferon-gamma as an effective ingredient and a pharmaceutically-acceptable carrier, and a method for treating and/or preventing the diseases with the agent. The HTLV-1-related diseases include ATL, rheumatoid arthritis, Sjögren's syndrome, SLE, uveitis, and immunopathies.
|
